You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Atomoxetine Hydrochloride

Showing 1 - 25 of 1,949
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Vasovagal Syncope Trial in Calgary (Atomoxetine Hydrochloride, Placebo)

Recruiting
  • Vasovagal Syncope
  • Atomoxetine Hydrochloride
  • Placebo
  • Calgary, Alberta, Canada
    University of Calgary
Jun 28, 2022

Bariatric Surgery and Pharmacokinetics of Atomoxetine

Recruiting
  • Obesity, Morbid
  • Trondheim, Norway
    St. Olavs University Hospital
Mar 21, 2022

Atomoxetine PBPK-PD Clinical Study

Completed
  • ADHD
  • Atomoxetine Hydrochloride
  • Kansas City, Missouri
    Children's Mercy Hospital and Clinics
Jun 20, 2022

Obstructive Sleep Apnea (OSA) Trial (AD109 (atomoxetine/aroxybutynin), Atomoxetine Hydrochloride, Placebo)

Not yet recruiting
  • Obstructive Sleep Apnea (OSA)
  • AD109 (atomoxetine/aroxybutynin)
  • +2 more
  • (no location specified)
Jun 25, 2021

Attention Deficit Disorder With Hyperactivity Trial in Washington (Mixed salts of a single-entity amphetamine, Atomoxetine HCl)

Completed
  • Attention Deficit Disorder With Hyperactivity
  • Mixed salts of a single-entity amphetamine
  • Atomoxetine hydrochloride
  • Washington, District of Columbia
    Washington Neuropsychological Institute, LLC
May 21, 2021

OSA - Obstructive Sleep Apnea Trial in United States (AD109, AD504, Atomoxetine Hydrochloride)

Completed
  • OSA - Obstructive Sleep Apnea
  • Los Angeles, California
  • +24 more
Dec 5, 2022

ADHD Trial in Boston (Mixed amphetamine salts (ADDERALL XR), Atomoxetine HCl)

Completed
  • ADHD
  • Mixed amphetamine salts (ADDERALL XR)
  • Atomoxetine hydrochloride
  • Boston, Massachusetts
    Massachusetts General Hospital
Jun 4, 2021

ADHD Trial in Worldwide (Guanfacine HCl (TAK-503), Atomoxetine HCl, Placebo)

Recruiting
  • Attention Deficit Hyperactivity Disorder
  • Guanfacine hydrochloride (TAK-503)
  • +2 more
  • Dothan, Alabama
  • +42 more
Aug 19, 2022

Obstructive Sleep Apnea Trial in Los Angeles, Saint Louis (Dosing 1: Atomoxetine, Dosing 2-4: AD313)

Completed
  • Obstructive Sleep Apnea
  • Dosing 1: Atomoxetine
  • Dosing 2-4: AD313
  • Los Angeles, California
  • +1 more
Oct 3, 2022

Attention-Deficit/Hyperactivity Disorder Trial in Worldwide (Lisdexamfetamine Dimesylate, Atomoxetine Hydrochloride)

Completed
Has Results
  • Attention-Deficit/Hyperactivity Disorder
  • Lisdexamfetamine Dimesylate
  • Atomoxetine Hydrochloride
  • Dothan, Alabama
  • +63 more
Jun 1, 2021

Obstructive Sleep Apnea, Down Syndrome Trial in Tucson (Atomoxetine and Oxybutynin (ato-oxy))

Not yet recruiting
  • Obstructive Sleep Apnea
  • Down Syndrome
  • Atomoxetine and Oxybutynin (ato-oxy)
  • Tucson, Arizona
    University of Arizona
Jun 26, 2023

Obstructive Sleep Apnea Trial in Boston (Placebo oral capsule, Atomoxetine Oral Capsule [Strattera])

Recruiting
  • Obstructive Sleep Apnea
  • Placebo oral capsule
  • Atomoxetine Oral Capsule [Strattera]
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 25, 2022

Obstructive Sleep Apnea, Hypertension Trial in Towson (AD113, Atomoxetine)

Recruiting
  • Obstructive Sleep Apnea
  • Hypertension
  • Towson, Maryland
    PCCAB
Jun 9, 2022

Obstructive Sleep Apnea Trial in Boston (Atomoxetine, Oxybutynin)

Not yet recruiting
  • Obstructive Sleep Apnea
  • Boston, Massachusetts
    Brigham and Women's Hospital
Sep 19, 2022

Tourette Syndrome Trial in Poitiers (Atomoxetine)

Recruiting
  • Tourette Syndrome
  • Poitiers, France
    CHU Poitiers
Jun 9, 2022

Cancer, Cognitive Late Effects Trial in Philadelphia (Atomoxetine)

Withdrawn
  • Cancer
  • Cognitive Late Effects
  • Philadelphia, Pennsylvania
    Temple University
Mar 30, 2022

OSA Trial in Boston (Atomoxetine 80 mg plus Oxybutynin 5 mg, Atomoxetine 80 MG, Placebo)

Not yet recruiting
  • OSA
  • Atomoxetine 80 mg plus Oxybutynin 5 mg
  • +2 more
  • Boston, Massachusetts
    Brigham and Womens Hospital
Jul 14, 2023

Neurogenic Orthostatic Hypotension Trial in New York, Nashville (Atomoxetine, Placebo)

Active, not recruiting
Has Results
  • Neurogenic Orthostatic Hypotension
  • New York, New York
  • +1 more
Aug 22, 2022

Obstructive Sleep Apnea Trial in Boston (Placebo, Acetazolamide, Trazodone)

Not yet recruiting
  • Obstructive Sleep Apnea
  • Placebo
  • +3 more
  • Boston, Massachusetts
    Sleep Disorders Research Program Brigham and Women's Hospital
Jul 18, 2022

ADHD Trial in Worldwide (Extended-release Guanfacine Hydrochloride, Atomoxetine Hydrochloride, Placebo Comparator)

Completed
Has Results
  • Attention Deficit Hyperactivity Disorder
  • Extended-release Guanfacine Hydrochloride
  • +2 more
  • San Diego, California
  • +65 more
Jun 10, 2021

Obstructive Sleep Apnea, Down Syndrome Trial in Tucson (Atomoxetine and oxybutynin (ato-oxy))

Recruiting
  • Obstructive Sleep Apnea
  • Down Syndrome
  • Atomoxetine and oxybutynin (ato-oxy)
  • Tucson, Arizona
    University of Arizona
Sep 27, 2021

Parkinson's Disease, Idiopathic Trial in Cleveland (Methylphenidate, Physical Therapy, Atomoxetine)

Recruiting
  • Parkinson's Disease, Idiopathic
  • Cleveland, Ohio
    Cleveland Clinic
Feb 15, 2022

Orthostatic; Hypotension, Neurogenic, Autonomic Failure, Pure Autonomic Failure Trial in Nashville (Accelerometer, pill,

Recruiting
  • Orthostatic; Hypotension, Neurogenic
  • +4 more
  • Accelerometer
  • +2 more
  • Nashville, Tennessee
    Autonomic Dysfunction Center/ Vanderbilt University Medical Cent
Mar 10, 2022

Tachycardia, Chronic Orthostatic Intolerance Trial in Nashville (drug, other, dietary supplement, radiation, procedure, device)

Active, not recruiting
  • Tachycardia
  • Chronic Orthostatic Intolerance
  • Nashville, Tennessee
    Vanderbilt University Autonomic Dysfunction Center
Sep 12, 2022

ADHD, Dyslexia Trial in New Haven (Atomoxetine, Placebo)

Completed
Has Results
  • Attention Deficit Hyperactivity Disorder
  • Dyslexia
  • New Haven, Connecticut
    Yale University School of Medicine
Oct 9, 2022